172 related articles for article (PubMed ID: 19716419)
1. Expression, purification and functional characterization of Wnt signaling co-receptors LRP5 and LRP6.
Fleury D; Vayssiere B; Touitou R; Gillard C; Lebhar H; Rawadi G; Mollat P
Protein Expr Purif; 2010 Mar; 70(1):39-47. PubMed ID: 19716419
[TBL] [Abstract][Full Text] [Related]
2. Role of the intracellular domains of LRP5 and LRP6 in activating the Wnt canonical pathway.
Mi K; Johnson GV
J Cell Biochem; 2005 May; 95(2):328-38. PubMed ID: 15778991
[TBL] [Abstract][Full Text] [Related]
3. Expression, purification and characterization of murine Dkk1 protein.
Fleury D; Gillard C; Lebhar H; Vayssière B; Touitou R; Rawadi G; Mollat P
Protein Expr Purif; 2008 Jul; 60(1):74-81. PubMed ID: 18456511
[TBL] [Abstract][Full Text] [Related]
4. Dkk1-mediated inhibition of Wnt signaling in bone results in osteopenia.
Li J; Sarosi I; Cattley RC; Pretorius J; Asuncion F; Grisanti M; Morony S; Adamu S; Geng Z; Qiu W; Kostenuik P; Lacey DL; Simonet WS; Bolon B; Qian X; Shalhoub V; Ominsky MS; Zhu Ke H; Li X; Richards WG
Bone; 2006 Oct; 39(4):754-66. PubMed ID: 16730481
[TBL] [Abstract][Full Text] [Related]
5. The binding between sclerostin and LRP5 is altered by DKK1 and by high-bone mass LRP5 mutations.
Balemans W; Piters E; Cleiren E; Ai M; Van Wesenbeeck L; Warman ML; Van Hul W
Calcif Tissue Int; 2008 Jun; 82(6):445-53. PubMed ID: 18521528
[TBL] [Abstract][Full Text] [Related]
6. Dkk1-induced inhibition of Wnt signaling in osteoblast differentiation is an underlying mechanism of bone loss in multiple myeloma.
Qiang YW; Barlogie B; Rudikoff S; Shaughnessy JD
Bone; 2008 Apr; 42(4):669-80. PubMed ID: 18294945
[TBL] [Abstract][Full Text] [Related]
7. The Wnt co-receptors Lrp5 and Lrp6 are essential for gastrulation in mice.
Kelly OG; Pinson KI; Skarnes WC
Development; 2004 Jun; 131(12):2803-15. PubMed ID: 15142971
[TBL] [Abstract][Full Text] [Related]
8. Low-density lipoprotein receptor-related protein 5 (LRP5) mediates the prostate cancer-induced formation of new bone.
Li ZG; Yang J; Vazquez ES; Rose D; Vakar-Lopez F; Mathew P; Lopez A; Logothetis CJ; Lin SH; Navone NM
Oncogene; 2008 Jan; 27(5):596-603. PubMed ID: 17700537
[TBL] [Abstract][Full Text] [Related]
9. Structure-based mutation analysis shows the importance of LRP5 beta-propeller 1 in modulating Dkk1-mediated inhibition of Wnt signaling.
Bhat BM; Allen KM; Liu W; Graham J; Morales A; Anisowicz A; Lam HS; McCauley C; Coleburn V; Cain M; Fortier E; Bhat RA; Bex FJ; Yaworsky PJ
Gene; 2007 Apr; 391(1-2):103-12. PubMed ID: 17276019
[TBL] [Abstract][Full Text] [Related]
10. Mesd is a universal inhibitor of Wnt coreceptors LRP5 and LRP6 and blocks Wnt/beta-catenin signaling in cancer cells.
Lu W; Liu CC; Thottassery JV; Bu G; Li Y
Biochemistry; 2010 Jun; 49(22):4635-43. PubMed ID: 20446724
[TBL] [Abstract][Full Text] [Related]
11. [Wnt signaling and bone metabolism].
Asaba H; Sakai J
Clin Calcium; 2005 May; 15(5):813-8. PubMed ID: 15876744
[TBL] [Abstract][Full Text] [Related]
12. Wnt-independent activation of beta-catenin mediated by a Dkk1-Fz5 fusion protein.
Holmen SL; Robertson SA; Zylstra CR; Williams BO
Biochem Biophys Res Commun; 2005 Mar; 328(2):533-9. PubMed ID: 15694380
[TBL] [Abstract][Full Text] [Related]
13. Novel LRP5 missense mutation in a patient with a high bone mass phenotype results in decreased DKK1-mediated inhibition of Wnt signaling.
Balemans W; Devogelaer JP; Cleiren E; Piters E; Caussin E; Van Hul W
J Bone Miner Res; 2007 May; 22(5):708-16. PubMed ID: 17295608
[TBL] [Abstract][Full Text] [Related]
14. A model for signaling specificity of Wnt/Frizzled combinations through co-receptor recruitment.
Verkaar F; Zaman GJ
FEBS Lett; 2010 Sep; 584(18):3850-4. PubMed ID: 20800062
[TBL] [Abstract][Full Text] [Related]
15. Genetic disorders of the LRP5-Wnt signalling pathway affecting the skeleton.
Koay MA; Brown MA
Trends Mol Med; 2005 Mar; 11(3):129-37. PubMed ID: 15760771
[TBL] [Abstract][Full Text] [Related]
16. Reduced affinity to and inhibition by DKK1 form a common mechanism by which high bone mass-associated missense mutations in LRP5 affect canonical Wnt signaling.
Ai M; Holmen SL; Van Hul W; Williams BO; Warman ML
Mol Cell Biol; 2005 Jun; 25(12):4946-55. PubMed ID: 15923613
[TBL] [Abstract][Full Text] [Related]
17. Kinases and G proteins join the Wnt receptor complex.
Quaiser T; Anton R; Kühl M
Bioessays; 2006 Apr; 28(4):339-43. PubMed ID: 16547943
[TBL] [Abstract][Full Text] [Related]
18. Reconstitution of a frizzled8.Wnt3a.LRP6 signaling complex reveals multiple Wnt and Dkk1 binding sites on LRP6.
Bourhis E; Tam C; Franke Y; Bazan JF; Ernst J; Hwang J; Costa M; Cochran AG; Hannoush RN
J Biol Chem; 2010 Mar; 285(12):9172-9. PubMed ID: 20093360
[TBL] [Abstract][Full Text] [Related]
19. The high bone mass family--the role of Wnt/Lrp5 signaling in the regulation of bone mass.
Johnson ML
J Musculoskelet Neuronal Interact; 2004 Jun; 4(2):135-8. PubMed ID: 15615112
[TBL] [Abstract][Full Text] [Related]
20. Analysis of association of LRP5, LRP6, SOST, DKK1, and CTNNB1 genes with bone mineral density in a Slovenian population.
Mencej-Bedrac S; Prezelj J; Kocjan T; Komadina R; Marc J
Calcif Tissue Int; 2009 Dec; 85(6):501-6. PubMed ID: 19898734
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
